<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Pedersen Rollins | Activity</title>
	<link>https://brycefoster.com/members/alloyepoch11/activity/</link>
	<atom:link href="https://brycefoster.com/members/alloyepoch11/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Pedersen Rollins.</description>
	<lastBuildDate>Sat, 25 Jul 2026 22:30:30 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b670769d3616e822d40e5642fb9a4b75</guid>
				<title>Pedersen Rollins posted an update: Multiple Myeloma Settlements: What Plaintiffs Need to Know [&#133;]</title>
				<link>https://brycefoster.com/activity/p/2145786/</link>
				<pubDate>Fri, 24 Jul 2026 03:31:39 +0000</pubDate>

									<content:encoded><![CDATA[<p><strong>Multiple Myeloma Settlements: What Plaintiffs Need to Know</strong> </p>
<p><em>A helpful, third‑person guide to the compensation landscape for people diagnosed with multiple myeloma who pursue legal claims.</em> </p>
<p>Introduction</p>
<p>Multiple myeloma is a plasma‑cell malignancy that has actually been linked in clinical literature to a number of occupational and pro&hellip;<span class="activity-read-more" id="activity-read-more-2145786"><a href="https://brycefoster.com/activity/p/2145786/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">166c4ce9a1d01021a671899238f6ceca</guid>
				<title>Pedersen Rollins posted an update: Navigating the Complexities: Why a Specialized Multiple [&#133;]</title>
				<link>https://brycefoster.com/activity/p/2145113/</link>
				<pubDate>Fri, 24 Jul 2026 02:26:31 +0000</pubDate>

									<content:encoded><![CDATA[<p>Navigating the Complexities: Why a Specialized Multiple Myeloma Attorney is Crucial for Affected Patients</p>
<p>Receiving a diagnosis of multiple myeloma is unquestionably life-altering. This aggressive cancer of plasma cells in the bone marrow brings tremendous physical, emotional, and monetary burdens. While improvements in treatment offer hope,&hellip;<span class="activity-read-more" id="activity-read-more-2145113"><a href="https://brycefoster.com/activity/p/2145113/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">928a86b528503b6a6a3bb7f75a054f3a</guid>
				<title>Pedersen Rollins posted an update: Navigating the Legal Landscape: When Multiple Myeloma Meets [&#133;]</title>
				<link>https://brycefoster.com/activity/p/2144982/</link>
				<pubDate>Fri, 24 Jul 2026 02:14:41 +0000</pubDate>

									<content:encoded><![CDATA[<p>Navigating the Legal Landscape: When Multiple Myeloma Meets the Need for Specialized Attorneys</p>
<p>A medical diagnosis of multiple myeloma, a cancer of plasma cells in the bone marrow, is exceptionally life-altering. Patients and their households instantly deal with a whirlwind of medical consultations, treatments like chemotherapy, stem cell&hellip;<span class="activity-read-more" id="activity-read-more-2144982"><a href="https://brycefoster.com/activity/p/2144982/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ca198194f7619a4a0a34ffdaecc73795</guid>
				<title>Pedersen Rollins became a registered member</title>
				<link>https://brycefoster.com/activity/p/2144650/</link>
				<pubDate>Fri, 24 Jul 2026 01:41:53 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>